CASI Pharmaceuticals Inc

NASDAQ:CASI  
1.59
-0.06 (-3.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)215.53M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.1 Million
Adjusted EPS-$0.05
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

CASI Pharmaceuticals Inc Stock, NASDAQ:CASI

9620 Medical Center Drive, Suite 300, Rockville, Maryland 20850
United States of America
Phone: +1.240.864.2600
Number of Employees: 144

Description

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.